Scientists at Massachusetts General Hospital and Boston University have made major progress on a bionic pancreas for those living with diabetes. On Sunday at the American Diabetes Association, ...

BATON ROUGE, La. (WAFB) - The FDA recently approved a device for diabetics, called the “bionic pancreas,” taking much of the burden of continually entering carb intake, off the user. With one entry ...

SAN FRANCISCO — Progress toward the development of a closed-loop "artificial pancreas" has hit a new milestone, improving blood glucose levels in adults and teenagers with type 1 diabetes for 5 days ...

Abbott Laboratories is back with another collaboration in the diabetes tech space. The Abbott Park, IL-based company announced an agreement with Beta Bionics, the developer of the iLet Bionic Pancreas ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated ...

Scientists have made big progress on a “bionic pancreas” to free some people with diabetes from the daily ordeal of managing their disease. A wearable, experimental device passed a real-world test, ...

Currently available semiautomated insulin-delivery systems require individualized insulin regimens for the initialization of therapy and meal doses based on carbohydrate counting for routine operation ...

A bionic pancreas is being developed by doctors at Massachusetts General Hospital and Boston University, with the goal of winning FDA approval. If it succeeds, this will likely be the first bionic ...

Ed Damiano, PhD, is working against the clock to produce a bionic pancreas that will help his son manage his Type 1 diabetes. The goal is to get FDA approval for the medical device before his son goes ...

SAN ANTONIO, Texas (Ivanhoe Newswire) – The FDA recently approved a device for diabetics, called the “bionic pancreas,” taking much of the burden of continually entering carb intake, off the user.

In our annual HealthLeaders 20, we profile individuals who are changing healthcare for the better. Some are longtime industry fixtures; others would clearly be considered outsiders. Some are revered; ...